Balchem (NASDAQ:BCPC) Posts Earnings Results, Misses Expectations By $0.08 EPS

Balchem (NASDAQ:BCPCGet Free Report) issued its quarterly earnings data on Friday. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08), Zacks reports. The firm had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 10.99% and a net margin of 12.90%.

Balchem Trading Up 1.5 %

Shares of BCPC stock opened at $163.72 on Friday. The stock’s fifty day moving average is $162.20 and its two-hundred day moving average is $169.34. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 2.98. The firm has a market capitalization of $5.32 billion, a P/E ratio of 44.01, a PEG ratio of 4.34 and a beta of 0.69. Balchem has a fifty-two week low of $137.69 and a fifty-two week high of $186.03.

Balchem Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, January 17th. Shareholders of record on Thursday, December 26th were issued a $0.87 dividend. The ex-dividend date of this dividend was Thursday, December 26th. This represents a yield of 0.4%. This is a positive change from Balchem’s previous annual dividend of $0.79. Balchem’s dividend payout ratio (DPR) is presently 23.39%.

Analyst Upgrades and Downgrades

BCPC has been the topic of a number of recent analyst reports. HC Wainwright increased their target price on Balchem from $185.00 to $190.00 and gave the company a “buy” rating in a research report on Monday, November 4th. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Get Our Latest Research Report on Balchem

Balchem Company Profile

(Get Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Recommended Stories

Earnings History for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.